학술논문
Olaparib as maintenance treatment in patients with chemosensitive small cell lung cancer (STOMP): A randomised, double-blind, placebo-controlled phase II trial
Document Type
Article
Author
Source
In Lung Cancer September 2022 171:26-33
Subject
Language
ISSN
0169-5002